WIDAPLIK 5 mg/1
telmisartan, amlodipine and indapamide · TABLET · Azurity Pharmaceuticals, Inc.
WIDAPLIK is a tablet containing telmisartan, amlodipine and indapamide at 5 mg/1, taken oral. Manufactured by Azurity Pharmaceuticals, Inc..
Key Facts
- Brand Name
- WIDAPLIK
- Generic Name
- telmisartan, amlodipine and indapamide
- NDC Code (Product)
24338-003- Manufacturer
- Azurity Pharmaceuticals, Inc.
- Strength
- 5 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA219423
- Drug Class
- Thiazide-like Diuretic [EPC]; Angiotensin 2 Receptor Blocker [EPC]
- Marketing Start
- 10/20/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is WIDAPLIK used for?
WIDAPLIK contains telmisartan, amlodipine and indapamide. It is a tablet taken oral. Consult your doctor for specific uses.
Is WIDAPLIK a controlled substance?
WIDAPLIK is not classified as a controlled substance by the DEA.
What is the generic name for WIDAPLIK?
The generic name for WIDAPLIK is telmisartan, amlodipine and indapamide. There are no other listed brand versions of telmisartan, amlodipine and indapamide.
What is the NDC code for WIDAPLIK 5 mg/1?
The NDC (National Drug Code) for WIDAPLIK 5 mg/1 is 24338-003, listed by Azurity Pharmaceuticals, Inc..
Other WIDAPLIK Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)